Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul J. Catalano, Sc.D.

Co-Author

This page shows the publications co-authored by Paul Catalano and Daphne Haas-Kogan.
Connection Strength

0.935
  1. Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysis. Neurooncol Pract. 2021 Oct; 8(5):569-580.
    View in: PubMed
    Score: 0.060
  2. Population-based estimates of survival among elderly patients with brain metastases. Neuro Oncol. 2021 04 12; 23(4):661-676.
    View in: PubMed
    Score: 0.060
  3. Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulation. J Neurol Neurosurg Psychiatry. 2021 Mar 09.
    View in: PubMed
    Score: 0.059
  4. Seizures Among Patients with Brain Metastases: A Population- and Institutional-level Analysis. Neurology. 2021 Jan 05.
    View in: PubMed
    Score: 0.059
  5. Hospice Utilization in Elderly Patients With Brain Metastases. J Natl Cancer Inst. 2020 12 14; 112(12):1251-1258.
    View in: PubMed
    Score: 0.059
  6. Utility of claims data for delineation of intracranial treatment among patients with brain metastases. Neuro Oncol. 2020 10 14; 22(10):1547-1548.
    View in: PubMed
    Score: 0.058
  7. Racial disparities in supportive medication use among older patients with brain metastases: a population-based analysis. Neuro Oncol. 2020 09 29; 22(9):1339-1347.
    View in: PubMed
    Score: 0.058
  8. Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases. Cancer. 2020 12 15; 126(24):5274-5282.
    View in: PubMed
    Score: 0.058
  9. Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study. Med Dosim. 2021 Spring; 46(1):21-28.
    View in: PubMed
    Score: 0.057
  10. Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study. J Neurooncol. 2020 Jul; 148(3):509-517.
    View in: PubMed
    Score: 0.056
  11. Utility of claims data for identification of date of diagnosis of brain metastases. Neuro Oncol. 2020 04 15; 22(4):575-576.
    View in: PubMed
    Score: 0.056
  12. Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases. Breast Cancer Res Treat. 2019 Jul; 176(1):171-179.
    View in: PubMed
    Score: 0.052
  13. Local control after brain-directed radiation in patients with cystic versus solid brain metastases. J Neurooncol. 2019 Apr; 142(2):355-363.
    View in: PubMed
    Score: 0.051
  14. Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis. World Neurosurg. 2019 Feb; 122:e1557-e1561.
    View in: PubMed
    Score: 0.051
  15. Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation. Radiother Oncol. 2018 03; 126(3):511-518.
    View in: PubMed
    Score: 0.048
  16. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017 Oct 19; 19(11):1511-1521.
    View in: PubMed
    Score: 0.047
  17. Brain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study. JAMA Oncol. 2017 Aug 01; 3(8):1069-1077.
    View in: PubMed
    Score: 0.046
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.